REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/02/2025
Back to search
Official data from USPTO
ADAPT PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADAPT PHARMA
ST13
US500000086975555Class
44
Filing
86975555
Registration
5014716
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
08/03/2025
Trademark type
Word
Nice classes
44
Filing date
11/27/2013
Registration date
08/02/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/09/2023
Last transaction
08/03/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2016-02-00
First use in commerce
2016-02-00
Drawing code
4
Owner type
24
Owner location
DUBLIN, IE
Examiner
MACFARLANE, JAMES
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
EMERGENT BIOSOLUTIONS IRELAND LIMITED
Adapt Pharma Limited
Representatives
Virginia Wolk Marino Crowell & Moring LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing healthcare and medical information for the treatment or prevention of conditions in the areas of women's healthcentral nervous systempainaddictioncardiovascular and oncologyall of the foregoing unrelated to ostomy products and preparations; healthcare servicesproviding information in the field of healthwellness and nutrition for the treatment or prevention of conditions in the areas of women's healthcentral nervous systempainaddictioncardiovascular and oncologyall of the foregoing unrelated to ostomy products and preparations
Publications
History of USPTO decisions and trademark events.
60 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/02/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/18/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/01/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/09/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2023
E815
TEAS SECTION 8 & 15 RECEIVED
10/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/23/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/23/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/23/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/02/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/03/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/03/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/28/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/25/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/02/2016
IUAF
USE AMENDMENT FILED
05/09/2016
EISU
TEAS STATEMENT OF USE RECEIVED
05/09/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/11/2016
EX2G
SOU EXTENSION 2 GRANTED
02/10/2016
EXT2
SOU EXTENSION 2 FILED
01/06/2016
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/09/2015
EX1G
SOU EXTENSION 1 GRANTED
07/08/2015
EXT1
SOU EXTENSION 1 FILED
06/29/2015
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/06/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2014
PUBO
PUBLISHED FOR OPPOSITION
11/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/22/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/22/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
09/22/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/22/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
09/22/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/22/2014
DPCC
DIVISIONAL PROCESSING COMPLETE
08/12/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/12/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2014
ALIE
ASSIGNED TO LIE
07/07/2014
DRRR
DIVISIONAL REQUEST RECEIVED
06/27/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/27/2014
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/27/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/19/2014
GNRT
NON-FINAL ACTION E-MAILED
03/19/2014
CNRT
NON-FINAL ACTION WRITTEN
03/19/2014
DOCK
ASSIGNED TO EXAMINER
03/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2013
NWAP
NEW APPLICATION ENTERED
11/30/2013
Continuous trademark protection
Get notified about every new filing that threatens ADAPT PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.